Zydus Lifesciences board to consider ₹5,000 crore fundraise

Zydus Lifesciences Limited announced its board of directors, at a meeting scheduled for November 6, 2025, will consider a proposal to raise funds up to ₹5,000 crores. This capital infusion could be achieved through the issuance of eligible securities via qualified institutional placements, rights issues, preferential allotments, private placements, or a combination of these methods, subject to shareholder and regulatory approvals.

The company plans to seek shareholder approval for this fund-raising initiative through a postal ballot process. This follows an earlier intimation about the board meeting on October 29, 2025.

In accordance with insider trading regulations, the trading window for dealing in Zydus Lifesciences securities for designated persons and their immediate relatives will remain closed until 48 hours after the conclusion of the board meeting.